Recruiting at 2 sites No phase Peripheral Arterial Disease (PAD)

Clinical trial for Peripheral Arterial Disease (PAD)

Official title Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

ClinicalTrials.gov ID: NCT07613840

What this study is testing

What is Aspirin?

An investigational oral antiplatelet drug being studied for peripheral arterial disease after lower extremity revascularization. is designed to inhibit cyclooxygenase-mediated thromboxane A2 production, reducing platelet aggregation.

Also referred to as Acetylsalicylic Acid; ASA.

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study is testing whether a personalized blood clot plan works better than standard care. It looks at how well it prevents clots, amputations, and bleeding.
Who it's for
You may be able to join if you have leg artery disease and had a procedure to fix blood flow.
What's involved
You would be picked by chance to get a custom plan or standard care. You would have blood tests to guide your medicine.
Time commitment
The study lasts one year with blood tests at 1 week and every few months.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients with a named arterial extremity injury or named vessel revascularization for atherosclerosis requiring open and/or closed revascularization.
  • Patients at the age of 18 or older

You likely can't join if

  • Patients who are younger than 18 years old
  • Known pregnancy (females of childbearing potential will have a pregnancy test prior to surgery as per standard of care)
  • Prisoners, defined as those who have been directly admitted from a correctional facility.
  • No atherosclerosis
  • Subject has active stomach ulcers
  • Subject has severe hepatic impairment
See the full eligibility criteria
Who can join
  • Patients with a named arterial extremity injury or named vessel revascularization for atherosclerosis requiring open and/or closed revascularization.
  • Patients at the age of 18 or older
What rules you out
  • Patients who are younger than 18 years old
  • Known pregnancy (females of childbearing potential will have a pregnancy test prior to surgery as per standard of care)
  • Prisoners, defined as those who have been directly admitted from a correctional facility.
  • No atherosclerosis
  • Subject has active stomach ulcers
  • Subject has severe hepatic impairment
  • Subject has a recent history of intracranial hemorrhage. If the patient has a history of cerebral hemorrhage with no new central nervous system disease of \>1 year, the study team will consult with the

The study team makes the final eligibility decision.

Where it is enrolling

  • Boston, Massachusetts, United States
  • Salem, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Boston, Massachusetts, United States; Salem, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.